FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES. CMN [Internet]. 2024 Nov. 12 [cited 2026 Aug. 3];6(2):7092-101. Available from: https://cahiersmagellanes.com/index.php/CMN/article/view/1040